Seer, Inc.

NASDAQ:SEER

Biotechnology

Healthcare
$1.44 +0.29%

+$0.01 today

Market cap
$80.37M
Beta
1.59
P/E (TTM)
-1.4
EPS (TTM)
-$1.26
52W Low $1.65High $2.41

Volume 0.23M

Average 0.32M

SEER Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Seer, Inc.NASDAQ: SEER

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) declines year over year

Q1 FY2026 weighted avg shares (diluted) of 56M shares fell 5.7% year over year, ahead of the -7.5% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 2.5% from the prior quarter. Over 3 fiscal years it compounded at -2.7% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -5.7% holds above the trailing-twelve-month pace of -7.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
56M-2.5% QoQ
Last fiscal yearDec 2025
57.45M-7.9% YoY
LTMMar 2026
56.96M-7.5% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.7%——
1 year-7.9%——
3-year CAGR-2.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
57.45M USD
Year-over-year change
-7.9%
4-year CAGR
-1.4%

Weighted Avg Shares (Diluted) vs competitors

How SEER compares with its peers on the latest reported figures

  • SEER's LTM Mar 2026 weighted avg shares (diluted) of 56.96M shares is the 14th highest of the 19 companies compared; the peer median is 74M shares.
  • Its year-over-year change of -7.5% is the lowest of 19, against a peer median of +15.5%.
  • Over three fiscal years its annual growth of -2.7% compares with a peer median of +18.6%.
SEER Competitors Peer median
Weighted Avg Shares (Diluted) for SEER and competitors
Company Period LTM YoY 3-year CAGR
SANASana Biotechnology, Inc.LTM Mar 2026257.25M +9.0%+10.4%
QSIQuantum-Si incorporatedLTM Mar 2026201.73M +31.6%+12.4%
NRIXNurix Therapeutics, Inc.LTM Aug 2026108.1M +31.0%+21.3%
CCCCC4 Therapeutics, Inc.LTM Mar 202696.61M +38.1%+19.3%
ORICORIC Pharmaceuticals, Inc.LTM Mar 202692.59M +31.1%+30.3%
KYMRKymera Therapeutics, Inc.LTM Jun 202691.85M +16.0%+16.1%
STTKShattuck Labs, Inc.LTM Mar 202684.8M +66.7%+18.0%
MLYSMineralys Therapeutics, Inc.LTM Jun 202679.68M +45.9%+135.7%
NKTXNkarta, Inc.LTM Mar 202674.08M +0.6%+19.3%
GLUEMonte Rosa Therapeutics, Inc.LTM Mar 202673.92M -0.7%+20.7%
PHVSPharvaris N.V.LTM Sep 202665.72M +16.6%+20.8%
FHTXFoghorn Therapeutics Inc.LTM Mar 202664.63M +7.9%+14.8%
CGEMCullinan Therapeutics, Inc.LTM Mar 202659.11M +2.4%+8.2%
SEERSeer, Inc.LTM Mar 202656.96M -7.5%-2.7%
MNOVMediciNova, Inc.LTM Mar 202649.09M +0.1%+0.0%
PEPGPepGen Inc.LTM Mar 202637.49M +15.0%+39.2%
MOLNMolecular Partners AGLTM Mar 202637.43M +9.0%+3.9%
ANTXAN2 Therapeutics, Inc.LTM Mar 202631.18M +4.3%+25.4%
LYELLyell Immunopharma, Inc.LTM Mar 202618.01M +34.2%+11.4%
Peer median (excluding SEER) 74M+15.5%+18.6%

Competitors are the stored peer set for SEER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.39M14.69M15.18M13.95M16.12M
Cost of Revenue6.77M14.3M13.73M7.12M14.22M
Gross Profit(374K)384K1.45M6.83M1.9M
Gross Margin-5.8%2.6%9.5%49.0%11.8%
Research & Development29.12M45.8M47.44M50.59M37.77M
Selling, General & Admin42.2M52.63M58.95M56.57M42.58M
Operating Expenses71.32M98.43M106.39M106.93M80.35M
Depreciation & Amortization3.56M5.9M5.58M6.18M6.1M
EBITDA(67.61M)(87.07M)(80.7M)(80.33M)(67.3M)
EBITDA Margin-1057.3%-592.9%-531.5%-575.9%-417.5%
Operating Income(71.7M)(98.04M)(104.94M)(100.1M)(78.45M)
Operating Margin-1121.3%-667.6%-691.2%-717.7%-486.7%
Interest Income326K4.6M17.76M16.67M11.52M
Interest Expense22K0000
Other Income / Expenses527K5.08M18.67M13.6M5.05M
Income Before Tax(71.17M)(92.97M)(86.28M)(86.5M)(73.4M)
Pre-Tax Margin-1113.1%-633.1%-568.3%-620.2%-455.4%
Income Tax Expense00098K201K
Net Income(71.17M)(92.97M)(86.28M)(86.6M)(73.6M)
Net Margin-1113.1%-633.1%-568.3%-620.9%-456.6%
EPS (Basic)(1.13)(1.42)(1.35)(1.39)(1.28)
EPS (Diluted)(1.13)(1.42)(1.35)(1.39)(1.28)
Weighted Avg Shares60.86M62.43M63.85M62.35M57.45M
Weighted Avg Shares (Diluted)60.86M62.43M63.85M62.35M57.45M

Seer, Inc.

NASDAQ:SEER

Intrinsic Alpha fair value

Locked

Current Price

$1.44

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.